mRNA-based SARS-CoV-2 vaccine candidate CVnCoV induces high levels of virus-neutralising antibodies and mediates protection in rodents

This article has been Reviewed by the following groups

Read the full article See related articles

Discuss this preprint

Start a discussion What are Sciety discussions?

Abstract

mRNA technologies have recently proven clinical efficacy against coronavirus disease 2019 and are among the most promising technologies to address the current pandemic. Here, we show preclinical data for our clinical candidate CVnCoV, a lipid nanoparticle-encapsulated mRNA vaccine that encodes full-length, pre-fusion stabilised severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) spike protein. In contrast to previously published approaches, CVnCoV is exclusively composed of naturally occurring nucleotides. Immunisation with CVnCoV induced strong humoral responses with high titres of virus-neutralising antibodies and robust T-cell responses. CVnCoV vaccination protected hamsters from challenge with wild-type SARS-CoV-2, demonstrated by the absence of viral replication in the lungs. Hamsters vaccinated with a suboptimal dose of CVnCoV leading to breakthrough viral replication exhibited no evidence of vaccine-enhanced disease. Overall, data presented here provide evidence that CVnCoV represents a potent and safe vaccine candidate against SARS-CoV-2.

Article activity feed

  1. SciScore for 10.1101/2020.10.23.351775: (What is this?)

    Please note, not all rigor criteria are appropriate for all manuscripts.

    Table 1: Rigor

    Institutional Review Board Statementnot detected.
    Randomizationnot detected.
    Blindingnot detected.
    Power Analysisnot detected.
    Sex as a biological variablenot detected.
    Cell Line Authenticationnot detected.

    Table 2: Resources

    Antibodies
    SentencesResources
    Specific proteins were detected using rabbit anti-SARS Spike c-terminal (Abcam, Cat. ab252690) and mouse anti tubulin (Abcam, Cat. ab7291), followed by goat anti-rabbit IgG IRDye® 800CW (Li-Cor, Cat. 926-32211) and goat anti-mouse IgG IRDye® 680RD (Li-Cor, Cat. 926-68070), respectively.
    anti tubulin
    suggested: None
    Specific S protein expression was assessed via staining with Human anti SARS CoV S antibody (CR3022)
    anti SARS CoV S
    suggested: None
    CR3022
    suggested: None
    MRO-1214LC) followed by goat anti-human IgG F(ab’)2 fragment PE antibody (Immuno Research, Cat. 109-116-097) in a BD FACS Canto II cell analyzer and the FlowJo 10 software.
    anti-human IgG
    suggested: (Jackson ImmunoResearch Labs Cat# 109-116-097, RRID:AB_2337677)
    Antibody analysis: Blood samples were taken via retro-orbital bleeding and SARS-CoV-2 S-specific IgG1 and IgG2a antibodies (mice) or total IgG (hamster) antibodies were detected via ELISA.
    SARS-CoV-2 S-specific IgG1
    suggested: None
    S-specific
    suggested: None
    IgG2a
    suggested: None
    total IgG
    suggested: None
    For detection, mouse sera were incubated with biotin rat anti-mouse IgG1 (BD Pharmingen, Cat. 550331) or biotin rat anti-mouse IgG2a (BD Pharmingen, Cat. 550332), hamster sera with biotin goat anti-hamster (Syrian) IgG antibody (BioLegend, Cat: 405601) followed by incubation with HRP-Streptavidin (BD, Cat: 554066).
    anti-mouse IgG1
    suggested: None
    anti-mouse IgG2a
    suggested: None
    anti-hamster ( Syrian ) IgG
    suggested: None
    The cells were then incubated with 200 ng/well of R-PE labelled rabbit anti-SARS-CoV-2 spike neutralizing monoclonal antibody (Sino Biological, Cat: 40592-R001) at 4°C for 2 h.
    anti-SARS-CoV-2
    suggested: None
    Antibody labelling with R-PE using the Zenon™ labelling kit for rabbit IgG (Invitrogen, Cat: Z25355) was performed according to the manufacturer’s instructions.
    rabbit IgG
    suggested: None
    The following antibodies were used for flow cytometry analysis: anti-Thy1.2 FITC (clone 53-2.1; Biolegend, Cat.14304)
    anti-Thy1.2 FITC
    suggested: (Abcam Cat# ab24905, RRID:AB_448475)
    Experimental Models: Cell Lines
    SentencesResources
    For detection of mRNA expression in cell culture, HeLa cells were seeded in 6-well plates at a density of 400.000 cells/well. 24h later, cells were transfected with 2μg of mRNA per well via Lipofection.
    HeLa
    suggested: None
    Quadruplicate, 10-fold serial dilutions were transferred to 96 well plates with Vero E6 cell culture monolayers and incubated for one hour at 37°C.
    Vero E6
    suggested: None
    Experimental Models: Organisms/Strains
    SentencesResources
    Mice (BALB/c, 8-12 weeks of age) were obtained from Janvier Laboratories (Le Genest-Saint-Isle, France).
    BALB/c
    suggested: None
    Software and Algorithms
    SentencesResources
    MRO-1214LC) followed by goat anti-human IgG F(ab’)2 fragment PE antibody (Immuno Research, Cat. 109-116-097) in a BD FACS Canto II cell analyzer and the FlowJo 10 software.
    FlowJo
    suggested: (FlowJo, RRID:SCR_008520)
    Antibody labelling with R-PE using the Zenon™ labelling kit for rabbit IgG (Invitrogen, Cat: Z25355) was performed according to the manufacturer’s instructions.
    Zenon™
    suggested: None

    Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).


    Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.

    Results from TrialIdentifier: No clinical trial numbers were referenced.


    Results from Barzooka: We did not find any issues relating to the usage of bar graphs.


    Results from JetFighter: We did not find any issues relating to colormaps.


    Results from rtransparent:
    • Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
    • Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
    • No protocol registration statement was detected.

    About SciScore

    SciScore is an automated tool that is designed to assist expert reviewers by finding and presenting formulaic information scattered throughout a paper in a standard, easy to digest format. SciScore checks for the presence and correctness of RRIDs (research resource identifiers), and for rigor criteria such as sex and investigator blinding. For details on the theoretical underpinning of rigor criteria and the tools shown here, including references cited, please follow this link.

  2. SciScore for 10.1101/2020.10.23.351775: (What is this?)

    Please note, not all rigor criteria are appropriate for all manuscripts.

    Table 1: Rigor

    Institutional Review Board Statementnot detected.Randomizationnot detected.Blindingnot detected.Power Analysisnot detected.Sex as a biological variableFemale Balb/c mice (n=8/group) were vaccinated IM on day 0, day 7, day 14 or day 21 with 2 µg of CVnCoV.Cell Line Authenticationnot detected.

    Table 2: Resources

    Antibodies
    SentencesResources
    Specific proteins were detected using rabbit anti-SARS Spike c-terminal (Abcam, Cat. ab252690) and mouse anti tubulin (Abcam, Cat. ab7291), followed by goat anti-rabbit IgG IRDye® 800CW (Li-Cor, Cat. 926-32211) and goat anti-mouse IgG IRDye® 680RD (Li-Cor, Cat. 926-68070), respectively.
    anti tubulin
    suggested: None
    Specific S protein expression was assessed via staining with Human anti SARS CoV S antibody (CR3022)
    anti SARS CoV S
    suggested: None
    CR3022
    suggested: None
    MRO-1214LC) followed by goat anti-human IgG F(ab’)2 fragment PE antibody (Immuno Research, Cat. 109-116-097) in a BD FACS Canto II cell analyzer and the FlowJo 10 software.
    anti-human IgG
    suggested: (Jackson ImmunoResearch Labs Cat# 109-116-097, RRID:AB_2337677)
    Antibody analysis Blood samples were taken via retro-orbital bleeding and SARS-CoV-2 S -specific IgG1 and IgG2a antibodies (mice) or total IgG (hamster) antibodies were detected via ELISA.
    IgG2a
    suggested: None
    total IgG
    suggested: None
    For detection, mouse sera were incubated with biotin rat anti-mouse IgG1 (BD Pharmingen, Cat. 550331) or biotin rat anti-mouse IgG2a (BD Pharmingen, Cat. 550332), hamster sera with biotin goat anti-hamster (Syrian) IgG antibody (BioLegend, Cat: 405601) followed by incubation with HRP-Streptavidin (BD, Cat: 554066).
    anti-mouse IgG1
    suggested: None
    anti-mouse IgG2a
    suggested: None
    anti-hamster ( Syrian ) IgG
    suggested: None
    The cells were then incubated with 200 ng/well of R-PE labelled rabbit anti-SARS-CoV-2 spike neutralizing monoclonal antibody (Sino Biological, Cat: 40592-R001) at 4°C for 2 h.
    anti-SARS-CoV-2
    suggested: (Abcam Cat# ab272854, RRID:AB_2847844)
    Antibody labelling with R-PE using the ZenonTM labelling kit for rabbit IgG (Invitrogen, Cat: Z25355) was performed according to the manufacturer’s instructions.
    rabbit IgG
    suggested: None
    The following antibodies were used for flow cytometry analysis: anti-Thy1.2 FITC (clone 53-2.1; Biolegend, Cat.14304)
    anti-Thy1.2 FITC
    suggested: (Abcam Cat# ab41584, RRID:AB_778437)
    Each dot represents an individual animal, bars depict the median. SECD: S ectodomain, RBD: receptor binding domain of S, NTD: N-terminal domain of S, nAb: neutralising antibody A ✱✱ C total IgG endpoint titer [Log10] d28 d42
    Log10
    suggested: None
    Experimental Models: Cell Lines
    SentencesResources
    Quadruplicate, 10-fold serial dilutions were transferred to 96 well plates with Vero E6 cell culture monolayers and incubated for one hour at 37°C.
    Vero E6
    suggested: None
    HeLa cells were transfected with 2 µg of the mRNA component of CVnCoV.
    HeLa
    suggested: CLS Cat# 300194/p772_HeLa, RRID:CVCL_0030)
    Experimental Models: Organisms/Strains
    SentencesResources
    For studies performed externally, Balb/c mice were provided and handled by Preclinics Gesellschaft für präklinische Forschung mbH, (Potsdam, Germany).
    Balb/c
    suggested: RRID:IMSR_ORNL:BALB/cRl)
    Bu ffe r ad + ot ei n pr C Vn C oV µg B D d35 d49 IgG1 endpoint titer 9 d28 8 6 5 4 3 2 1 0 9 8 7 6 5 4 3 2 1 0 1st vacc d0 d7 d14d21 d0 d0 2nd vacc none + d0 d7 d14d21 d0 d0 2 d28
    1st vacc d0 d7 d14d21 d0 d0 2nd vacc none + d0 d7 d14d21 d0 d0 2
    suggested: None
    CVnCoV 2µg C d0 d7 d14d21 d0 d0 d28 protein + adj.
    C d0 d7 d14d21 d0 d0 d28 protein + adj
    suggested: None
    IFN+/TNF+(% of CD4 T cells) IgG2a endpoint titer CD4 T-cells ✱✱ 0.8 0.6 0.4 0.2 0.0 d0 d7 d14 d21 d7 d7 + buffer CD8 T-cells 1st vacc 2nd vacc d28 d0 d7 d14 d21 d7 d7 none d35 d0 d7 d14 d21 d7 d7 d28 CVnCoV 2µg
    d7 d14 d21 d7 d7
    suggested: None
    vacc d28 d0 d7 d14 d21 d7 d7 none d35 d0 d7 d14 d21 d7 d7 d28
    suggested: None
    d0 d7 d14 d21 d7 d7 d28 protein + adj. buffer IFN+ TNF+(% of CD8 T cells) VNT ✱✱✱ ✱✱ ✱✱ ✱ d0 d7 d14 d21 d7 d7 CVnCoV 2µg protein + adj. buffer Figure 2: CVnCoV elicits high levels of humoral and cellular immune responses.
    d0 d7 d14 d21 d7 d7 d28 protein + adj
    suggested: None
    VNT ✱✱✱ ✱✱ ✱✱ ✱ d0 d7 d14 d21 d7 d7 CVnCoV 2µg protein + adj
    suggested: None
    ✱✱ d56 ✱✱ Throat swab titration [Log10 TCID50/ml] d5 d5 d5 d5 d6 d5 d5 d5 d5 d6 d5 d5 d5 d5 d6 untr.
    Log10 TCID50/ml ] d5 d5 d5 d5 d6 d5 d5 d5 d5 d6 d5 d5 d5 d5 d6
    suggested: None
    Software and Algorithms
    SentencesResources
    Flow cytometry data were analyzed using FlowJo software (Tree Star, Inc, Ashland, USA.).
    FlowJo
    suggested: (FlowJo, RRID:SCR_008520)

    Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).


    Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.


    Results from TrialIdentifier: No clinical trial numbers were referenced.


    Results from Barzooka: We found bar graphs of continuous data. We recommend replacing bar graphs with more informative graphics, as many different datasets can lead to the same bar graph. The actual data may suggest different conclusions from the summary statistics. For more information, please see Weissgerber et al (2015).


    Results from JetFighter: We did not find any issues relating to colormaps.


    About SciScore

    SciScore is an automated tool that is designed to assist expert reviewers by finding and presenting formulaic information scattered throughout a paper in a standard, easy to digest format. SciScore checks for the presence and correctness of RRIDs (research resource identifiers), and for rigor criteria such as sex and investigator blinding. For details on the theoretical underpinning of rigor criteria and the tools shown here, including references cited, please follow this link.